Hyperprolinemia Type 2

Watchlist
Retrieved
2021-01-23
Source
Trials
Drugs

Hyperprolinemia type 2 is an autosomal recessive proline metabolism disorder due to pyroline-5-carboxylate dehydrogenase deficiency. The condition is often benign but clinical signs may include seizures, intellectual deficit and mild developmental delay.